Press Releases

GW and the FDA have published a BioCompute Object Specification Document for research and clinical trial use, which details a new framework for communication of High-throughput Sequencing computations and data analysis, known as BioCompute Objects. 
The GW School of Medicine and Health Sciences is pleased to announce the creation of the Office of Integrative Medicine and Health within the Department of Clinical Research and Leadership.
A study by Jyoti K. Jaiswal, MSC, PhD, at Children's National and Adam Horn, graduate student at GW School of Medicine and Health Sciences, was published in Science Signaling. The study looks at how mitochondria help repair injured muscles by triggering increased production of reactive oxygen…
The GW Hospital is expanding its robotic services, becoming the first hospital in the world to perform colorectal surgery with the Medrobotics Flex® Robotic System – a robot system designed to navigate the body’s twists and turns. 
GW researcher received an almost $2 million grant to study the body's natural defenses against HIV in order to drive development of better vaccines and therapies.
Eric Vilain, MD, PhD, will serve as chair and professor of the newly re-named Department of Genomics and Precision Medicine at the GW School of Medicine and Health Sciences and Children’s National Health System.
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the results of an international research study conducted with the George Washington University (GW) School of Medicine & Health Sciences evaluating the…
A research team led by Adam Friedman, MD, associate professor of dermatology at SMHS, has found that topically applied nitric oxide-releasing nanoparticles are a viable treatment for deep fungal infections of the skin caused by dermatophytes.
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at GW Cancer Center, accepted a check from the Avon Foundation at the annual Avon Walk in Washington, D.C. The money will fund a patient navigator who will provide resources to help breast cancer…
A team of researchers at GW Cancer Center found that T-cells lacking in the HDAC11 enzyme performed better in attacking cancer tumor cells. This research highlights the importance of treating HDAC11 as an immunotherapeutic target.